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Abstract
Undifferentiated rat pheochromocytoma (PC12) cells extend neurites when cultured in the presence of nerve growth
factor (NGF). Extracellular guanosine synergistically enhances NGF-dependent neurite outgrowth. We investigated the
mechanism by which guanosine enhances NGF-dependent neurite outgrowth. Guanosine administration to PC12 cells
significantly increased guanosine 3¶,5¶-cyclic monophosphate (cGMP) within the first 24 h whereas addition of soluble
guanylate cyclase (sGC) inhibitors abolished guanosine-induced enhancement of NGF-dependent neurite outgrowth. sGC
may be activated either by nitric oxide (NO) or by carbon monoxide (CO). N!-Nitro-L-arginine methyl ester (L-NAME), a
non-isozyme selective inhibitor of nitric oxide synthase (NOS), had no effect on neurite outgrowth induced by guanosine.
Neither nNOS (the constitutive isoform), nor iNOS (the inducible isoform) were expressed in undifferentiated PC12 cells,
or under these treatment conditions. These data imply that NO does not mediate the neuritogenic effect of guanosine. Zinc
protoporphyrin-IX, an inhibitor of heme oxygenase (HO), reduced guanosine-dependent neurite outgrowth but did not
attenuate the effect of NGF. The addition of guanosine plus NGF significantly increased the expression of HO-1, the
inducible isozyme of HO, after 12 h. These data demonstrate that guanosine enhances NGF-dependent neurite outgrowth
by first activating the constitutive isozyme HO-2, and then by inducing the expression of HO-1, the enzymes responsible
for CO synthesis, thus stimulating sGC and increasing intracellular cGMP.
Introduction
The roles of extracellular purine nucleosides and nucleo-
tides as neurotransmitters and modulators are well docu-
mented [1]. Extracellular purines also exert trophic effects
on cells; influencing growth, division [2, 3] differentiation,
and even apoptosis [4Y6]. Purines are released from cells
under physiological conditions, acting as neurotransmitters
and neuromodulators [7Y9]. Trauma and other insults to the
central nervous system are also potent stimuli that cause
the release of purines [3], most of which are converted by
ectoenzymes to adenosine and guanosine [3, 5]. After
insults to cells, more guanine-based than adenine-based
purines are released [10]. Furthermore, the extracellular
concentration of guanosine remains elevated for prolonged
periods in vitro [10] and for up to a week after central
nervous system (CNS) injury [11], implying that extracel-
lular guanosine may exert trophic effects in vivo.
Sprouting of neurites, which later become axons and
dendrites, is an important change associated with neural
development and differentiation [12, 13]. Neurite sprout-
ing through regeneration or collateral sprouting also plays
an important role in the functional recovery following
injury to the central or peripheral nervous systems [14].
Amongst its trophic effects, guanosine stimulates neurite
outgrowth and enhances NGF-dependent neurite outgrowth
[3, 15].
PC12 cells serve as a useful model for studying cell
signaling [16]. They respond to many growth factors,
neurotrophins and hormones, which initiate multiple
signaling pathways [17Y20]. The specific cellular targets
of these signaling pathways mediate the distinct responses
of differentiation, proliferation and survival, all of which
can be assessed [16]. The addition of NGF to PC12 cells
causes a sustained activation of ERK, a mitogen-activated
protein kinase, through activation of the TrkA receptor
[16, 19]. This leads to the development of many pheno-
typic characteristics in PC12 cells, which are also associ-
ated with mature sympathetic neurons [13, 21].
Extracellular guanosine not only stimulates neurite
outgrowth from primary cultures of rat hippocampal
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neurons [3], and PC12 cells [15] but also enhances the
neuritogenic effects of NGF on PC12 cells [15, 22, 23].
Both in astrocytes [24] and in PC12 cells [22], guanosine
increases intracellular adenosine 3¶,5¶-cyclic monophos-
phate (cAMP). Some of the neuritogenic effects of guano-
sine in PC12 cells appeared to be mediated through this
mechanism [22]. However, guanosine also has cAMP-
independent effects, synergistic with NGF, because its ef-
fects are not abolished by an adenylate cyclase inhibitor
[22] and are synergistic with substances that increase intra-
cellular cAMP [15].
The cAMP-independent component of the signal trans-
duction mechanism through which guanosine syner-
gistically enhances NGF-dependent neurite outgrowth is
unknown. However, several lines of evidence indicate a
role for guanosine 3¶,5¶-cyclic monophosphate (cGMP).
First, extracellular guanosine increases intracellular cGMP
in rat mesenteric artery [25]. Second, nitric oxide (NO)
donors enhance NGF-dependent PC12 cell neurite out-
growth via a cGMP-dependent mechanism; and thirdly, the
neuritogenic effects of the NO donors are abolished by
guanylyl cyclase inhibitors and mimicked by cGMP
analogs [26]. The mechanism by which cGMP enhances
neurite outgrowth is currently unclear.
Nitric oxide synthases are a family of enzymes, which
synthesize NO through the catalytic conversion of L-arginine
to L-citrulline. The constitutively expressed forms are the
endothelial (eNOS) or neuronal (nNOS), which are regulat-
ed by the cytosolic concentration of Ca2+ [27]. The in-
ducible isoform (iNOS) is widely distributed, and becomes
active only hours after an inducing event [28]. NO is
involved in cell communication and signal transduction in
many systems including the CNS [29Y31]. NGF induced
different isoforms of NOS in PC12 cells after 4 days in vitro
[32, 33]. Peunova and Enikolopov [32] reported that the NO
produced preceding the development of the differentiated
phenotype is due predominantly to iNOS.
The diffusible gas carbon monoxide (CO) is a putative
neurotransmitter [34]. Heme oxygenase (HO) synthesizes
CO from the biologically active substrate biliverdin, which
is rapidly reduced to bilirubin, and iron from intracellu-
lar heme [34]. CO can modulate activities attributed to
cGMP in the nervous system [35Y38]. It has been pro-
posed that CO production is responsible for baseline
cGMP levels in the hippocampus [36]. In cerebellar gran-
ule cell cultures, CO produced by HO affects intracellular
cGMP concentrations by modulating the NO-soluble
guanylate cyclase signaling system [39]. Conversely,
NO, synthesized by NOS may induce the expression of
HO-1 [40Y42], indicating a close and reciprocal interac-
tion between the NOS-NO and the HO-CO signaling
systems [35, 36]. Based on these findings it has been
proposed that a possible role for HO-1 is to counteract NO
toxicity [43].
Together, these data led us to question whether guano-
sine enhanced NGF-dependent neurite outgrowth is
through a mechanism involving cGMP, and if so, whether
it was attributable to the stimulation of either NO or CO
synthesis.
Materials and methods
Cell culture and treatments
Tissue culture supplies were from Life Technologies. All
other supplies were obtained from Sigma RBI unless
otherwise stated. 2.5S NGF was a generous gift from
Dr. M. Coughlin, Department of Medicine, McMaster Uni-
versity, 6-(phenylamino)-5,8-quinolinedione (LY83583)
was obtained from (Calbiochem), copper protoporphyrin
from (Porphyrin Products), and zinc protoporphyrin IX
from (Research Biochemical).
PC12 cells were maintained in either RPMI 1640
medium supplemented with 5% heat-inactivated (HI) fetal
calf serum (FCS), 5% HI-horse serum (HS) and 1%
antibioticYantimycotic (AntiYAnti; 10,000 units of penicil-
lin, 10,000 mg of streptomycin, 25 mg amphotericin B/ml in
0.85% saline) [15] or F-12K (Kaighn’s Modification)
medium supplemented with 15% HI-HS, 2.5% HI-FCS,
and 1% AntiYAnti at 37 -C in a 5% CO2 environment.
Neurite outgrowth assay
To evaluate the effect of test compounds on neurite
outgrowth in PC12 cells, they were added to cultures for
48 h as previously described [15]. Briefly, PC12 cells were
plated onto poly-D,L-ornithine (PORN)-coated 24-well
plates at a density of 2.5  104 cells/well. Cells were cul-
tured in RPMI 1640 supplemented with 1.5% HI-HS, 1.5%
HI-FCS and 1% AntiYAnti. Guanosine was dissolved in
10% sodium hydroxide (1N NaOH) and when added to the
culture medium the final concentration was 0.01% sodium
hydroxide. In experiments in which guanosine (300 mM)
was added to each well first, followed within 15 min by the
addition of 2.5S NGF (40 ng/ml). Methylene blue,
LY83583, hemoglobin, N!-nitro-L-arginine methyl ester
(L-NAME), copper protoporphyrin-IX (CuPP) and zinc
protoporphyrin-IX (ZnPP), were added 15 min prior to
the addition of guanosine. All test substances remained
in the medium throughout the 48-h test period. Cells
were maintained at 37 -C in a humidified atmosphere of
95% air, 5% CO2. After 48 h, cells were fixed with 10%
formalin in phosphate buffered saline (PBS), pH 7.4 for
10 min and stored at 4 -C in PBS (pH 7.4) containing
sodium azide (0.1%, w/v) until counted (usually within
2 weeks). Total cell number was determined by counting
two randomly selected areas in each well. The observer
was blind to the treatments the cells had received. At
least 50 cells per well were counted, and the number of
cells bearing one or more neurites determined using a
NIKON Diaphot microscope equipped with phase contrast
optics. Neurites were defined as processes extending at
least one cell body diameter from the cell with growth
cones at their tips [44].
Western immunoblot analysis
The expression of HO-1, HO-2, iNOS, nNOS, and b-actin
in PC12 cells was determined by Western immunoblot
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analysis. PC12 cells were seeded onto PORN-coated plates
at a density of 1  106 cells/plate and maintained at 37- for
48 h prior to treatments. Cells were placed in a medium
containing 3% HI-FCS and 3% HI-HS 12 h before the start
of treatments. Cells were then treated with various agents
for 0, 6, 12, 24, or 48 h. At the end of the treatment period
cells were washed once with PBS and then harvested at
4 -C using a lysis buffer (25 mM Tris/HCl pH 7.4, 10 mM
NaCl, 10 mM EDTA, 100 ml/10 ml Tween 20, 10 mM
sodium pyrophosphate decahydrate, 10 mM sodium ortho-
vanadate, 5 mg/ml leupeptin, 10 mM glycerophosphate).
Cells were disrupted by sonication and aliquots (25 ml)
were removed for the determination of protein concen-
trations using the bicinchoninic acid (BCA) protein assay
(Pierce, Illinois, USA). Cells lysates were separated on
12% SDS-polyacrylamide gels and electrophoretically
transferred to nitrocellulose membranes (PALL, Michigan,
USA). Membranes were incubated with a specific primary
antibody overnight at 4 -C then were exposed to a
secondary antibody for 1 h at room temperature. Positive
control peptides for nNOS and iNOS (obtained from
Cayman Chemical, Ann Arbor. MI) were used as electro-
phoresis standard. The following antibodies were used:
monoclonal antibody to brain NOS (Sigma, dilution:
1:1,000), monoclonal antibody to the inducible NOS
(Sigma, dilution: 1:1,000), anti-iNOS/bNOS, goat anti-
mouse IgG-HRP (StressGen Biotechnologies, dilution
1:100,000), monoclonal antibody to b-actin (abCAM,
dilution: 1:20,000), monoclonal anti-b-actin, goat anti-
mouse IgG-HRP (Novus Biological, dilution 1:100,000),
monoclonal antibody to HO-1 (StressGen Biotechnologies,
dilution 1:2,000), anti-HO-1, goat anti-mouse IgG-HRP
(StressGen Biotechnologies, dilution 1:200,000), rabbit
polyclonal antibody to HO-2/HO-1 (StressGen Biotechnol-
ogies, dilution 1:1,000), anti HO-2/HO-1, goat anti-rabbit
IgG-HRP (StressGen Biotechnologies, dilution 1:200,000).
Immunocomplexes were then visualized using a chemilu-
minescence substrate (Sigma-Aldrich). Immunoblots were
quantified by densitometric analyses, using the Northern
Eclipse program (EPIX). All bands on the immunoblots
were normalized to their corresponding b-actin bands prior
to statistical analysis.
Determination of cyclic GMP
PC12 cells were seeded onto PORN-coated 12-well plates
at a density of 5  105 cells/well and maintained at 37 -C
for 48 h prior to treatments. Cells were placed in a medium
containing 3% HI-FCS and 3% HI-HS 12 h before the start
of treatments. Cells were then treated with various agents
for different times (0, 6, 12, 24, or 48 h). At the end of the
treatment period cGMP was extracted and analyzed using a
cGMP enzyme immunoassay (EIA) kit (Amersham Bio-
sciences). The assay is based on a competition between
unlabeled cGMP in the sample or (standard) and a fixed
quantity of peroxidase-labeled cGMP for a limited number
of binding sites on a cGMP specific antibody. With fixed
amounts of antibody and cGMPYperoxidase conjugate, the
amount of bound cGMPYperoxidase conjugate is inversely
proportional to the concentration of unlabeled cGMP.
Statistical analysis
Statistical analysis was carried out using a two-way
ANCOVA, when applicable, or a two-way ANOVA fol-
lowed by Fischer’s LSD test for multiple comparisons.
Results
Guanosine enhances NGF-dependent neurite outgrowth
via activation of soluble guanylate cyclase
As we have reported previously, we have evaluated the
effect of guanosine on NGF-dependent neurite outgrowth
during the first 48 h, as guanosine most likely exerted its
effects within the first 1Y2 h after treatment [23]. There-
fore, all experiments reported in this manuscript were
performed during the first 48 h of PC12 cell treatment with
various agents.
PC12 cells contain both soluble, and particulate isoforms
of guanylate cyclase (GC) [26, 45]. To determine whether
activation of GC was necessary for the neuritogenic effect
of guanosine, inhibitors of GC were added for 48 h to
PC12 cells treated with NGF plus guanosine. Methylene
blue at concentrations ranging from 0.1 to 1 mM was
added to PC12 cell cultures that contained NGF alone
(40 ng/ml), or guanosine (300 mM) plus NGF (40 ng/ml).
Cultures were then evaluated for neurite outgrowth. At the
concentrations used in these experiments, methylene blue
inhibits sGC but not particulate GC [46, 47]. Methylene
blue had no effect on the outgrowth of neurites induced
by NGF alone (Figure 1). However, in cultures treated
with both guanosine and NGF, the addition of methylene
blue reduced significantly (P G 0.01) the proportion of
neurite-bearing cells in a concentration-dependent manner
(Figure 1). LY83583 inhibits both, particulate GC and sGC
[48]. When LY83583 (10 nM) was added to PC12 cell
cultures, it inhibited neurite outgrowth elicited by guano-
sine plus NGF but had no effect on neurite outgrowth in
cultures treated with NGF alone (data not shown). These
data support the hypothesis that cGMP plays a role in
enhancing the effect of guanosine on NGF-mediated
neurite outgrowth. Moreover, since methylene blue at the
concentrations used inhibits soluble but not particulate GC,
these data imply that guanosine activates sGC.
Guanosine may activate sGC either directly, or indirectly
by stimulating the formation of NO, CO or hydroxyl rad-
icals, which are all physiological activators of sGC [49].
To distinguish between these possibilities we added
hemoglobin (100 nM) to cultures of PC12 cells. Extracel-
lular hemoglobin directly scavenges NO and CO because
these substances avidly bind to the heme moiety, thereby
inhibiting their GC activating activity [46]. Hemoglobin
reduced the synergistic effects of guanosine on NGF-
mediated neurite outgrowth but had no effect on neurite
outgrowth elicited by NGF alone (data not shown).
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Although these data imply that guanosine stimulates the
synthesis of a sGC-activating factor, they do not show
whether this factor is NO, CO or hydroxyl radical.
Inhibition of nitric oxide synthase (NOS) has no effect on
guanosine-enhanced NGF-dependent neurite outgrowth
In the rat mesenteric artery, guanosine stimulates NO
formation [25]. Therefore, we investigated if guanosine
could also stimulate NO synthesis in PC12 cells. To
examine whether NO was involved in the signal transduc-
tion pathway that mediated the enhancement of neurite
outgrowth by guanosine through sGC, we inhibited the
enzyme NOS, which catalyzes the conversion of L-arginine
to L-citrulline plus NO. The L-arginine analog, N!-nitro-
L-arginine methyl ester hydrochloride (L-NAME) [50]
inhibits NOS competitively [25, 51]. In this experiment,
we reduced the concentration of L-arginine in the culture
medium from 1 mM to 80 mM, thus permitting more
effective competition of the NOS inhibitor with L-arginine.
Under these conditions, L-NAME inhibits NOS at 10 mM
[25, 51]. When added to the culture medium of PC12
cells at 10 mM L-NAME did not inhibit NGF-dependent
neurite outgrowth, and had no effect on the guanosine-
mediated enhancement of NGF-dependent neurite out-
growth (Figure 2a). To confirm that NO was not involved
in the signal transduction pathway that mediates the
enhancement of neurite outgrowth by guanosine, we
determined the expression of two subtypes of NOS
isoenzymes: iNOS, the inducible isoform (Figure 2b), and
nNOS, the constitutive isoform (Figure 2c). PC12 cultures
were exposed to guanosine alone (300 mM), or NGF alone
(40 ng/ml), or to the combination of guanosine plus NGF
for 48 h, and NOS expression was determined by Western
immunoblot analysis. We analyzed various protein con-
centrations (5Y50 mg/ml) and determined b-actin expres-
sion on the same Western immunoblots. Using protein
concentrations as high as 50 mg/ml neither nNOS nor iNOS
expression could be detected in PC12 cells treated with
guanosine, or NGF, or the combination of the two agents.
These data indicate that since NOS is not expressed during
the first 48 h of treatment, thus NO cannot mediate the
effect of guanosine on neurite outgrowth.
Inhibition of heme oxygenase (HO) attenuates
guanosine-enhanced NGF-dependent neurite outgrowth
Since NO apparently did not mediate the effects of gua-
nosine, we examined the possibility that guanosine stimu-
lated CO synthesis. Heme oxygenase (HO), the enzyme
which synthesizes CO, has been detected in rat adrenal
glands [52]. Zinc protoporphyrin-IX (ZnPP) inhibits both
the constitutive HO (HO-2) and the inducible HO (HO-1)
isoforms of this enzyme [52, 53]. We, therefore, tested the
effect of increasing concentrations of ZnPP on the ability
of NGF or, NGF plus guanosine to induce neurite out-
growth. Addition of ZnPP (0.01, 0.1, 1 mM) to PC12 cell
cultures did not significantly reduce outgrowth of neurites
induced by NGF (Figure 3), when compared to control
cultures. In contrast, ZnPP attenuated the ability of
guanosine to enhance NGF-stimulated neurite outgrowth
(Figure 3). As a control for non-specific effects of metallo-
porphyrins we used copper protoporphyrin-IX (CuPP),
which does not inhibit heme oxygenase [54]. The addition
of CuPP to PC12 cells did not inhibit either NGF-depen-
dent neurite outgrowth or the ability of guanosine to enhance
NGF-dependent neurite outgrowth (data not shown).
Guanosine induces heme oxygenase-1 (HO-1) expression
PC12 cells have been previously shown to express both
HO-1 and HO-2 proteins under basal conditions [55]. Since
the addition of ZnPP to PC12 cultures decreased NGF-
dependent neurite outgrowth, we attempted to establish
whether guanosine treatment had any effect on the
expression of the HO-1 protein during the first 48 h of
this process. We treated PC12 cultures with guanosine
alone (300 mM), or with NGF alone (40 ng/ml), or with a
combination of guanosine plus NGF for 48 h, and
determined HO-1 expression by Western immunoblot
analysis. We used the monoclonal antibody directed
Figure 1. Methylene blue attenuates guanosine-enhanced nerve growth
factor-dependent neurite outgrowth in PC12 cells. PC12 cells were
cultured in RPMI 1640 medium supplemented with 5% heat-inactivated
fetal calf serum, 5% heat-inactivated horse serum and 1% antibio-
ticYantimycotic for 48 h. Cultures were then treated with NGF (40 ng/
ml) or NGF (40 ng/ml) plus guanosine (300 mM) and with increasing
concentrations of methylene blue (0Y1 mM). After 48 h, the total cell
number and number of cells bearing one or more neurites were determined
by counting two random areas in each well. The mean proportion of
neurite-bearing cells in cultures treated with NGF was approximately
25%Y35%. Because this value varied slightly between experiments, all
experimental values are expressed relative to the NGF treated cultures,
which was defined as 100%. Open bars: NGF treatment, closed bars: NGF
plus guanosine treatment. Cultures treated with guanosine plus NGF had a
significantly (P G 0.01, two-way independent ANOVA) greater proportion
of neurite-bearing cells than those treated with NGF alone. Methylene
blue (0.1 to 1.0 mM) had no effect on the proportion of neurite-bearing
cells in cultures treated with NGF alone, but at concentrations from 0.1 to
1.0 mM, it significantly (**P G 0.01, two-way independent ANOVA)
reduced the proportion of neurite-bearing cells in cultures treated with
guanosine plus NGF. Data represent the mean T SEM of 12 determinations
from two replicate experiments.
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against rat HO-1, which recognizes a single protein band,
at 32 kDa, the reported molecular weight for this enzyme
[36] (Figure 4b). Western immunoblots were quantified
and normalized against their corresponding b-actin band.
Statistical analysis revealed no differences in b-actin
expression for any of the treatments at the different time
points (data not shown); therefore, this was used as a
control for normalizing HO-1 protein expression. There
was no significant change in HO-1 expression in untreated
PC12 cells during the 48-h period. In cells exposed to
guanosine alone HO-1 expression, unexpectedly, was
significantly reduced at 6 h compared to untreated cells at
0 time (P G 0.05), and at 6 h (P G 0.01) (Figure 4). A
possible explanation for this result may stem from the
observation that HO-1 gene expression is suppressed by
elevated intracellular calcium concentrations [56] and
guanosine has been shown to increase intracellular calcium
concentrations in astrocytes [57]. Since increases in
calcium are rapid and transient, this may account for the
reduced HO-1 expression at 6 h. The addition of NGF,
however, is sufficient to override this effect and so at later
time points HO-1 expression is up-regulated by the
combination of NGF and guanosine. The addition of
guanosine plus NGF significantly increased HO-1 expres-
sion at 12 h (P G 0.05), compared to that of control cells at
0 time (Figure 4). After 24 h all three treatments
(guanosine alone, or NGF alone or guanosine plus NGF)
led to a significant increase in HO-1 expression compared
to control cells at 0 time (P G 0.01) (Figure 4). In cells
exposed to guanosine alone the enhanced HO-1 expression
at 24 h was also significantly different from that detected
in untreated cells at 24 h (P G 0.05). Whereas in cells
Figure 2. (a) Inhibition of nitric oxide synthase has no effect on the proportion of neurite-bearing PC12 cells cultured for 48 h in the presence of NGF,
or NGF plus guanosine. PC12 cells were cultured with NGF (40 ng/ml) or NGF (40 ng/ml) plus guanosine (300 mM) as described in Figure 1. Cultures
were treated with the general nitric oxide synthase inhibitor, L-NAME (0.1Y10 mM) for 48 h and the number of cells bearing one or more neurites were
determined as described in Figure 1. Open bars: NGF treatment, closed bars: NGF plus guanosine treatment. Neurite outgrowth in cultures treated with
guanosine plus NGF was significantly (P G 0.01, two-way independent ANOVA) greater than in cultures treated with NGF alone. L-NAME (0.1Y10 mM)
had no effect on the proportion of neurite bearing cells in cultures treated with NGF alone, or in combination with guanosine. Data represent the mean T
SEM of 12 determinations from two replicate experiments. (b) Inducible nitric oxide synthase is not expressed in PC12 cells cultured for 48 h in the
presence of guanosine, or NGF, or guanosine plus NGF. PC12 cells were cultured on plates coated with poly-D,L-ornithine for 72 h. Cells were then
grown in serum-reduced medium (3% heat-inactivated fetal calf serum and 3% heat-inactivated horse serum) for 12 h, and were treated with guanosine
(G, 300 mM) or NGF (N, 40 ng/ml) or guanosine (300 mM) plus NGF (40 ng/ml) (G + N), or with no added treatments (C). The expression of inducible
nitric oxide synthase was determined at various time points (6, 12, 24 and 48 h) by Western immunoblot analysis. Recombinant inducible nitric oxide
synthase protein (50 ng) was used as a positive control (P). Immunoblots were quantified by densitometric analysis and were normalized to the
corresponding b-actin bands as described in the Materials and methods. Statistical analysis was performed using a two-way ANCOVA followed by
Fischer’s LSD post-hoc comparison test. Data presented are representative of at least three independent experiment. (c) Neuronal nitric oxide synthase is
not expressed in PC12 cells cultured for 48 h in the presence of guanosine, or NGF, or guanosine plus NGF. PC12 cells were cultured as described in
panel (b), and the expression of neuronal nitric oxide synthase was determined at various time points (6, 12, 24 and 48 h) by Western immunoblot
analysis. Recombinant neuronal nitric oxide synthase protein (50 ng) was used as a positive control (P). Immunoblots were quantified by densitometric
analysis and were normalized to the corresponding b-actin bands as described in the Materials and methods. Statistical analysis was performed using a
two-way ANCOVA followed by Fischer’s LSD post-hoc comparison test. Data presented are representative of at least three independent experiment.
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treated with NGF alone, or with the combination of NGF
plus guanosine this difference was significant at P G 0.01
(Figure 4). After 48 h, HO-1 expression was elevated sig-
nificantly only in cells exposed to NGF alone when com-
pared to untreated cells at 0 time, and at 48 h (P G 0.05) for
both comparisons. In cells exposed to guanosine alone or to
NGF plus guanosine HO-1 expression by 48 h declined and
was similar to untreated control values at 0 time and at
48 h.
In parallel experiments, we determined whether guano-
sine had an effect on the expression of the constitutive
isoform, HO-2 in these cells. We treated PC12 cultures
with guanosine alone (300 mM), or NGF alone (40 ng/ml),
or in combination guanosine plus NGF for 48 h and
determined HO-2 expression by Western immunoblot
analysis. Using the monoclonal antibody directed against
rat HO-2 we detected a single protein band, of molecular
weight 36 kDa, as described for HO-1 [36] (Figure 5b).
Western immunoblots were quantified and normalized
against their corresponding b-actin band. Again, statistical
analysis revealed no differences in b-actin expression for
any of the treatments at the different time points (data not
shown), therefore, this was used as a control for normal-
izing HO-2 protein bands. HO-2 expression was detectable
at 0 time in untreated PC12 cells, but none of the
treatments had any significant effect on its expression at
any time point determined. In the guanosine-treated cells
HO-2 expression was elevated slightly at 12 h, but this was
not statistically significant.
Guanosine increases intracellular cGMP concentrations in
PC12 cells during guanosine-enhanced NGF-dependent
neurite outgrowth
CO is a known activator of sGC [36]. Since we have shown
that HO-1 expression is elevated in PC12 cells exposed to
guanosine, we next investigated whether this increased
HO-1 expression is accompanied by elevation in intracel-
lular cGMP concentrations. PC12 cell cultures were treated
with guanosine alone (300 mM), or NGF alone (40 ng/ml),
or in combination guanosine plus NGF for 48 h. Intracel-
lular cGMP concentrations were determined after 6, 12, 24
and 48 h of treatment. In cells exposed to guanosine alone,
cGMP concentrations increased significantly after 6 h com-
pared to untreated cells at this time point (P G 0.05). In
PC12 cells treated with guanosine plus NGF, cGMP
concentrations increased significantly after 6 h compared
to untreated cells at 0 time (P G 0.05), remained sig-
Figure 4. Guanosine induces the expression of heme oxygenase-1 protein
in PC12 cells. PC12 cells were cultured on plates coated with poly-D,L-
ornithine for 72 h. Cells were then grown in serum-reduced medium (3%
heat-inactivated fetal calf serum and 3% heat-inactivated horse serum) for
12 h, and were treated with guanosine (G, 300 mM) or NGF (N, 40 ng/ml)
or guanosine (300 mM) plus NGF (40 ng/ml) (G + N), or with no added
treatments (C) as described in Figure 2b. The expression of heme
oxygenase-1 was determined at various time points (6, 12, 24 and 48 h)
by Western immunoblot analysis. Immunoblots were quantified by
densitometric analysis and were normalized to the corresponding b-actin
bands as described in the Materials and methods. Open bars: untreated
controls (C), closed bars: guanosine plus NGF (G + N) treatment, stippled
bars: NGF (N) treatment, hatched bars: guanosine (G) treatment. Statistical
analysis was performed using a two-way ANCOVA followed by Fischer’s
LSD post-hoc comparison test (: P G 0.05 compared with control time
point 0); (:: P G 0.01 compared with time point 0); (* P G 0.05 compared
with control at same time point); (** P G 0.01 compared with control at
same time point). (a) Data represent the mean optical density T SEM
obtained in six independent experiments. (b) Results are representative
Western immunoblots obtained in these experiments.
Figure 3. Inhibition of heme oxygenase attenuates guanosine-enhanced
NGF-dependent neurite outgrowth in PC12 cells. PC12 cells were cultured
with NGF (40 ng/ml) or NGF (40 ng/ml) plus guanosine (300 mM) as
described in Figure 1. Some cultures were treated with the selective
inhibitor of heme oxygenase zinc protoporphyrin-IX (0.01Y1 mM) for
48 h and the number of cells bearing one or more neurites was determined
as described in Figure 1. Open bars: NGF treatment, closed bars: NGF
plus guanosine treatment. Cultures treated with guanosine plus NGF had a
significantly (P G 0.01 two-way independent ANOVA) greater proportion
of neurite-bearing cells than cultures treated with NGF alone. Zinc
protoporphyrin-IX significantly decreased (**P G 0.01) the neurite growth
from cultures treated with guanosine plus NGF, but had no significant
effect on neurite outgrowth in cultures treated with NGF alone. Data
represent the mean T SEM of 12 determinations from two replicate
experiments.
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nificantly elevated at 12 h (P G 0.05) and at 24 h (P G 0.05),
and declined to values comparable to control by 48 h.
Inhibition of heme oxygenase (HO) attenuates intracellular
cGMP concentrations in PC12 cells during guanosine
enhanced NGF-dependent neurite outgrowth
Previous experiments have demonstrated that the HO in-
hibitor, ZnPP, blocked guanosine enhanced NGF-depen-
dent neurite outgrowth of PC12 cells (Figure 3). We have
also shown that HO-1 expression and cGMP concentrations
were elevated during the first 12Y24 h of this neurite
outgrowth process (Figures 4 and 6, respectively). We
therefore examined whether pre-treatment of cells with the
HO inhibitor ZnPP had any effect on cGMP concentra-
tions. Although metalloporphrins, such as ZnPP-IX have
been used widely to demonstrate the role for this enzyme
in numerous physiological situations, their selectivity for
HO has been questioned; as they may also inhibit
haemoproteins such sGC and NOS [58]. However, metal-
loporphrins used at a concentration below 10 mM are more
selective for HO [59]. Since we found that ZnPP, at
100 nM concentration significantly attenuated guanosine-
enhanced neurite outgrowth (Figure 3), we used this
concentration of ZnPP to test its effect on intracellular
cGMP concentration. PC12 cell cultures were exposed to
guanosine alone (300 mM), or NGF alone (40 ng/ml), or
in combination guanosine plus NGF for 12 h. ZnPP (100
nM) was added to some cultures prior to the addition of
guanosine, or NGF, or NGF plus guanosine, and
intracellular cGMP concentrations were determined. In
cells exposed to guanosine alone, or to guanosine plus
NGF, cGMP concentrations were significantly elevated
compared to untreated cells (P G 0.01) and to cells treated
with NGF alone (P G 0.01) (Figure 7). In cultures pre-
treated with ZnPP, cGMP concentrations were significantly
reduced in cells exposed to guanosine alone (P G 0.05), or
guanosine plus NGF (P G 0.05) compared to the corres-
ponding treatments without the inhibitor. Treatment of
PC12 cells with NGF did not increase intracellular cGMP
concentrations, and the addition of ZnPP had no effect on
cGMP concentrations.
Discussion
Addition of guanosine to cultures of undifferentiated,
NGF-naı¨ve PC12 cells modestly increases the proportion
of cells with neurites after 48 h and, in cultures treated with
Figure 6. Guanosine increases cGMP concentrations during guanosine-
enhanced NGF-dependent neurite outgrowth in PC12 cells. PC12 cells
were cultured on plates coated with poly-D,L-ornithine for 72 h. Cells
were then grown in serum-reduced medium (3% heat-inactivated fetal calf
serum and 3% heat-inactivated horse serum) for 12 h, and were treated
with guanosine (G, 300 mM) or NGF (N, 40 ng/ml) or guanosine (300 mM)
plus NGF (40 ng/ml) (G + N), or with no added treatments (C) as
described in Figure 2b. Cells were lysed at time points 0, 6, 12, 24, and
48 h and cGMP concentrations were determined by a competitive enzyme
immunoassay. Open bars: untreated controls (C), closed bars: guanosine
plus NGF (G + N) treatment, stippled bars: NGF (N) treatment, hatched
bars: guanosine (G) treatment. Statistical analysis was performed using a
two-way ANCOVA followed by Fischer’s LSD post-hoc comparison test
(: P G 0.05, compared to time point 0); (* P G 0.05, relative to control);
(** P G 0.01, relative to control); (D P G 0.05, relative to NGF). Data
presented represent the mean relative optical density T SEM obtained in
six independent experiments.
Figure 5. Guanosine has no effect on heme-oxygenase-2 protein
expression in PC12 cells. PC12 cells were cultured on plates coated with
poly-D,L-ornithine for 72 h. Cells were then grown in serum-reduced
medium (3% heat-inactivated fetal calf serum and 3% heat-inactivated
horse serum) for 12 h, and were treated with guanosine (G, 300 mM) or
NGF (N, 40 ng/ml) or guanosine (300 mM) plus NGF (40 ng/ml) (G + N),
or with no added treatments (C) as described in Figure 2b. The expression
of heme oxygenase-2 was determined at various time points (6, 12, 24 and
48 h) by Western immunoblot analysis. Immunoblots were quantified by
densitometric analysis and were normalized to the corresponding b-actin
bands as described in the Materials and methods. Open bars: untreated
controls (C), closed bars: guanosine plus NGF (G + N) treatment, stippled
bars: NGF (N) treatment, hatched bars: guanosine (G) treatment.
Statistical analysis was performed using a two-way ANOVA. (a) Data
represent the mean optical density T SEM obtained in three independent
experiments. (b) Results are representative Western immunoblots obtained
in these experiments.
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maximally effective concentrations of NGF, addition of
guanosine produces a significant further increase in the
proportion of neurite-bearing cells [15]. This implied that
the effects of NGF and guanosine are mediated through
distinct signaling systems. We reported previously that,
whereas some of the neuritogenic effects of guanosine
were mediated by increases in intracellular cAMP [22, 23],
there was also a cAMP-independent component [22].
Several points led us to consider that a signaling pathway
involving cGMP may be responsible for the cAMP-
independent component. Vuorinen et al. [25] had shown
that extracellular guanosine increases intracellular cGMP
in rat mesenteric artery through a NO-dependent mecha-
nism; nitric oxide donors enhance NGF-dependent PC12
cell neurite outgrowth via a cGMP-dependent mechanism
[26]; and the neuritogenic effects of the NO donors are
abolished by guanylyl cyclase inhibitors and mimicked by
cGMP analogs [26]. Our data indicated that indeed cGMP
is involved in the neuritogenic effects of guanosine in
PC12 cells, but, surprisingly, that NO is not.
Increases in intracellular cGMP are often due to acti-
vation of GC by NO [35, 45]. Schulick et al. [60] dem-
onstrated that activation of GC by NO donors or atrial
natriuretic peptide enhanced NGF-dependent neurite out-
growth in PC12 cells. Further, in PC12 cells NGF up-
regulates NOS expression, and NO plays an important role
in their cellular differentiation [32]. However, NGF-
induced differentiation of undifferentiated NGF-naı¨ve
PC12 cells could not be abolished by inhibitors of sGC,
and NO alone is not sufficient to induce PC12 cell
differentiation [26, 33].
In the experiments reported here, pre-treating undiffer-
entiated, NGF-naı¨ve PC12 cells with the NOS inhibitor
L-NAME, had no effect on the guanosine-enhanced NGF-
induced neurite outgrowth. Moreover, like others [61, 62],
we found that neither nNOS nor iNOS isoforms were
expressed during the first 48 h of cellular differentiation of
PC12 cells. Therefore, NO cannot mediate the neuritogenic
effects of guanosine on PC 12 cells during the first 48 h.
Rather than NO, our data indicated that CO might
activate sGC in response to guanosine in undifferentiated
PC12 cells. The heme oxygenase inhibitor, ZnPP attenuat-
ed both the ability of guanosine to enhance NGF-dependent
neurite outgrowth, and its ability to increase intracellular
cGMP, alone or in the presence of NGF. This led us to
conclude that guanosine either activated constitutive HO-2
or induced the expression of either HO-1 and/or the HO-2
isoforms of this enzyme.
Our data indicated that, as others have reported [55],
both HO-1 and HO-2 were expressed constitutively in
PC12 cells under basal cell culture conditions. Guanosine
induced a significant increase in the expression of HO-1
protein at 24 h in undifferentiated PC12 cells, but had no
significant effect on HO-2 expression. Guanosine, in the
presence of NGF, produced an even more rapid and
pronounced enhancement of HO-1 expression, which was
detectable after 12 h. Treatment of PC12 cells with NGF
alone also increased the expression of HO-1. Several
authors reported recently that NGF promotes HO-1 gene
transcription in PC12 cells [63, 64] via activation of the
MEK pathway. HO-1 mediates the anti-oxidative and anti-
apoptotic effects of NGF in serum-deprived PC12 cells
[63]. In PC12 cells exposed to oxidative stress induced by
6-hydroxy dopamine, NGF promotes HO-1 upregulation,
in this case via the PI3K/Akt/PKB pathway [64].
Others [63, 64] have reported increased HO-1 protein by
6Y9 h after exposure to NGF, whereas in our study we
observed no change in HO-1 protein concentration until
24 h after NGF addition. This discrepancy may be due to
a difference in the PC12 cell line, or to the experimental
conditions to which the cells were exposed.
We did not expect to find inhibition of HO-1 protein
expression by guanosine at 6 h. It has been reported
however, that the HO-1 gene expression is suppressed by
the elevation of intracellular calcium concentration [56].
Since we have found that guanosine increases intracellular
calcium concentrations in astrocytes [57], similar mecha-
nisms may downregulate HO-1 expression in PC12 cells at
the 6-h time point. As the guanosine-stimulated calcium
increases are rapid and transient, at later time points
(12Y24 h) other intracellular pathways, such as the MAPK
and PI-3 kinase pathways are activated, and these are
known to promote HO-1 gene expression. Most likely, by
48 h these pathways are no longer activated.
In contrast to HO-1, neither guanosine nor NGF, alone
or in combination with guanosine, affected HO-2 expres-
sion. This confirms the results of others who have found
Figure 7. Inhibition of heme oxygenase attenuates cGMP concentrations
during guanosine enhanced NGF-dependent neurite outgrowth in PC12
cells. PC12 cells were cultured on plates coated with poly-D,L-ornithine
for 72 h. Cells were then grown in serum-reduced medium (3% heat-
inactivated) fetal calf serum and 3% heat-inactivated horse serum) for
12 h, and were treated with guanosine (G, 300 mM) or NGF (N, 40 ng/ml)
or guanosine (300 mM) plus NGF (40 ng/ml) (G + N), or with no added
treatments (C) as described in Figure 2b. The selective inhibitor of heme
oxygenase, zinc protoporphyrin-IX (100 nM), was added to some cultures
prior to the addition of guanosine, or NGF, or guanosine plus NGF. Cells
were lysed after 12 h and cGMP concentrations were determined by a
competitive enzyme immunoassay. Open bars: no zinc protoporphyrin-IX
added, closed bars: zinc protoporphyrin-IX added. Statistical analysis was
performed using a one-way ANOVA followed by Fischer’s LSD post-hoc
comparison test (** P G 0.01, relative to control); (DD P G 0.01, relative to
NGF); (: P G 0.05, relative to treatment without zinc protoporphyrin-IX).
Data presented represent the mean relative optical density T SEM obtained
in six independent experiments.
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that HO-2 is not regulated by NGF [63, 64]. The HO-1
isozyme is induced by diverse intracellular signals
(reviews: Maines [36], Immenshchuh and Ramadori [65]),
that include some of the pathways which activate protein
kinases, such as PKA [66], or PKC [67, 68], or the second
messenger cGMP [42] most likely via PKG [69]. These
pathways likely converge on nuclear effectors such as the
nuclear factor-kB (NF-kB), activator protein-1 (AP-1) and
heat shock factor, to enhance HO-1 gene transcription by
interacting with the regulatory elements in the promoter
region the gene [36, 65].
We reported previously that inhibition of transport of
guanosine into PC12 cells did not affect its neuritogenic
activity [23], raising the possibility that its effects are
mediated by activation of a cell surface, membrane-bound
receptor. Indeed, recently we have identified and pharmaco-
logically characterized a specific binding site for guanosine
in rat brain membranes [70], in cultured astrocytes [71] and
in PC12 cells (F. Caciagli et al., unpublished observations),
with characteristics of a Gi-protein coupled receptor [5, 70].
Occupation of this putative receptor by guanosine activates
the MAPK pathway [5] and the PI3K/Akt/PKB pathway
[72, 73]. These effects are most likely mediated by the b,g-
subunit of the Gi-protein, coupled to the guanosine receptor
[74Y76]. Guanosine has also been shown to increase in-
tracellular cAMP concentrations in several cell types
[22Y24] and phosphorylate the cAMP binding protein,
CREB (F. Caciagli et al., unpublished observations).
In PC12 cells NGF-promoted induction of HO-1 expres-
sion requires the activation of the MEK/ERK pathway [63]
and the PI3K/Akt/PKB pathway [64]. Since guanosine, via
its putative receptor may also stimulate these intracellular
pathways, HO-1 expression in PC12 cells may be regulated
by similar mechanisms.
Guanosine plus NGF in combination induce HO-1
expression to a similar extent than NGF alone at 6, 12
and 24 h. At 48 h, however the effect of guanosine plus
NGF on HO-1 expression is comparable to that of control
and lower than NGF alone. Since the mechanisms that
induce HO-1 expression are complex, the roles played by
guanosine and NGF, and the time course of these effects
are unclear. We have shown, however that guanosine alone
is insufficient to cause major neurite outgrowth. It does
however enhance the NGF-induced neuritogenesis. Neu-
ritogenesis is not solely due to HO-1 expression. Either
HO-1 or HO-2 could be responsible for these early events
since ZnPP, a non-selective HO inhibitor reduces the con-
centration of cGMP elicited by guanosine or guanosine
plus NGF by 12 h.
NGF activates a number of signalling pathways in PC12
cells, including the MAP kinase and PI3-kinase pathway
[18] and the c-JUN N-terminal kinases (JNKs.) [20].
Induction of the HO-1 gene by these pathways seems to
override the inhibitory effect of guanosine on HO-1 ex-
pression. HO-1 expression at 12 and 24 h is upregulated to
a similar extent by guanosine alone, or by NGF alone or by
guanosine plus NGF, so there is no additive effect of the
combination treatment. As the mechanisms involved in
HO-1 gene induction are complex and not clearly defined,
our results suggest that the activation of these processes by
the three treatments is comparable.
At 48 h HO-1 expression in cells treated with guanosine
alone, or guanosine plus NGF is similar to control. In the
NGF-treated cells, however HO-1 expression is still
significantly upregulated compared to control. We attribute
this to a difference in the time course of HO-1 gene
activation by guanosine, and NGF. Since NGF-activated
intracellular signalling pathways are complex and manifold
[18, 20] these effects may persist for a longer time. These
results are different from those we obtained at 6 h. At this
time point, the only significant effect on HO-1 expression
is its inhibition by guanosine alone, and this may be due to
downregulation of HO-1 expression by guanoisne-stimu-
lated elevations in intracellular Ca2+ concentrations as
described above.
In several types of cells, HO-1 expression is regulated by
the NO-cGMP pathway (reviewed by Maines [36]). In the
case of guanosine this mechanism is not likely to play a
significant role, as neither iNOS, nor nNOS was detected
in NGF-treated PC12 cells during the first 48 h of
guanosine-promoted neurite outgrowth.
In contrast, upregulation of HO-1 expression by activa-
tion of the constitutive HO-2 via the transcription factor
NF-kB, is a very plausible alternative mechanism [36].
HO-2 may be activated by PKC, which in turn is stim-
ulated by increased intracellular calcium concentrations
[77]. PKC may also activate sGC directly, by phosphory-
lation, thus providing a receptor-mediated elevation of
cGMP concentrations in PC12 cells [78]. We have shown
that guanosine increases intracellular calcium concentra-
tions under certain conditions [57], and this in turn may
activate PKC. Thus, guanosine may activate HO-2 in a
calcium-dependent manner. The time course of intracellu-
lar cGMP elevation elicited by guanosine, or by guanosine
plus NGF, is consistent with this hypothesis. In PC12 cells
exposed to guanosine alone, or to guanosine and NGF,
cGMP concentrations were significantly elevated by 6 h
and until 12 h in cells exposed to guanosine plus NGF.
Although the addition of NGF to PC12 cells induces HO-1
expression at 24 and 48 h, this treatment does not increase
cGMP concentrations. Initially we were also puzzled by
these data, as we expected a parallel increase in the cGMP
concentrations with this treatment. It has been reported by
Liu et al. [79] that NGF treatment of PC12 cells rapidly
decreases sGC mRNA and protein in a transcription- and
translation-dependent manner. So our interpretation of these
results is that although HO-1 protein is upregulated by
NGF, there is a concurrent suppression of sGC expression,
so no increase in cGMP is detected under these conditions.
In addition, NGF may also inhibit the activities of some
phosphodiesterase isoforms, and thus decrease intracellular
cGMP concentrations [80].
Since HO-1 expression in the guanosine treated cells
was not observed until 24 h, and since neither iNOS nor
nNOS was detectable at these times, our data is most
parsimoniously explained by activation of HO-2.
Although we have not determined HO-2 activity, we
have shown, using Western immunoblot analysis that this
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isozyme is expressed in PC12 cells constitutively, through-
out the time course of the experiment (from 0 to 48 h)
during all treatment conditions.
CO synthesized by HO-1 and HO-2 will bind and
activate sGC, increasing intracellular cGMP [35Y38] and
this in turn may activate protein kinase G (PKG) [81, 82]
and regulate phosphodiesterases (PDE) [81, 82]. Our data
are compatible with the neuritogenic effects of guanosine
being mediated by cGMP, possibly from early activation of
HO-2, and later the induction of HO-1, leading to CO
generation, and activation of sGC. But how these molec-
ular events enhance neuritogenesis is unknown. CO itself
may directly activate several intracellular signaling path-
ways, including the MAPK pathway [83] and p38 MAPK
[84], the transcription factor NF-kB [85] and induce the
transcription of immediate early genes [37, 38].
Recently, Xiang et al. [86] proposed that navigation of
growing axons in response to guidance cues, is mediated
by Gi protein coupled receptors, via elevation of cytosolic
cGMP [86]. This is another mechanism by which guano-
sine may promote differentiation of PC12 cells.
In conclusion, we have demonstrated the importance of
HO, CO and cGMP in mediating the neuritogenic effect
of guanosine. The relationship of this signaling mecha-
nism to the putative Gi-protein-linked receptor for guano-
sine is currently the subject of active investigation in our
laboratories.
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